Insiders · Profile

GRIFFIN MICHELLE RENEE

Director at Adaptive Biotechnologies. Filing since 14 Oct 2020. CIK 0001229765

Company
Date
Role
Action
Shares
Amount
Of holding
25 Jun 2026
Director
Sold on a plan
52,084
$1.05M
76.9%
11 Mar 2026
Director
Sold at will
15,394
$214.13K
49.6%
3 Mar 2026
Director
Sold on a plan
48,044
$735.07K
75.7%
13 Mar 2025
Director
Sold at will
36,291
$260.93K
70.2%
6 Mar 2025
Director
Sold on a plan
15,664
$124.37K
23.3%
27 Mar 2023
Director
Sold at will
2,341
$19.88K
10.2%
27 Aug 2021
Director
Sold, plan not stated
14,916
$522.06K
90.8%
14 Jul 2021
Director
Sold, plan not stated
2,500
$92.00K
62.4%
17 Jun 2021
Director
Sold, plan not stated
4,000
$160.00K
72.7%
14 Jun 2021
Director
Sold, plan not stated
2,500
$96.40K
62.4%
18 May 2021
Director
Sold, plan not stated
2,500
$87.50K
62.4%
14 Apr 2021
Director
Sold, plan not stated
4,500
$195.35K
75.0%
16 Mar 2021
Director
Sold, plan not stated
1,500
$70.50K
49.9%
15 Mar 2021
Director
Sold, plan not stated
4,500
$187.86K
75.0%
16 Feb 2021
Director
Sold, plan not stated
6,000
$390.48K
80.0%
14 Jan 2021
Director
Sold, plan not stated
6,000
$395.25K
100%
14 Dec 2020
Director
Sold, plan not stated
6,000
$353.04K
100%
16 Nov 2020
Director
Sold, plan not stated
6,000
$286.13K
100%
14 Oct 2020
Director
Sold, plan not stated
12,000
$634.10K
100%
19 decisions on file.